These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7785747)

  • 21. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
    Azevedo M; Castel-Branco MG; Oliveira JF; Ramos E; Delgado L; Almeida J
    Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levocabastine eye drops versus sodium cromoglycate in seasonal allergic conjunctivitis.
    Wihl JA; Rudblad S; Kjellén H; Blychert LA
    Clin Exp Allergy; 1991 May; 21 Suppl 2():37-8. PubMed ID: 1680537
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies comparing the efficacy of nedocromil sodium eye drops with sodium cromoglycate and placebo in seasonal allergic conjunctivitis.
    Leino M
    Ocul Immunol Inflamm; 1993; 1(1-2):23-6. PubMed ID: 22827187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levocabastine versus cromolyn sodium in the treatment of pollen-induced conjunctivitis.
    Ciprandi G; Cerqueti PM; Sacca S; Cilli P; Canonica GW
    Ann Allergy; 1990 Aug; 65(2):156-8. PubMed ID: 1974402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis.
    Davies BH; Mullins J
    Allergy; 1993 Oct; 48(7):519-24. PubMed ID: 7902022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis.
    Abelson MB; Weintraub D
    Eur J Ophthalmol; 1994; 4(2):91-101. PubMed ID: 7950341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anti-allergic effects of a cromolyn sodium-chlorpheniramine combination compared to ketotifen in the conjunctival allergen challenge model.
    Leonardi A; Busca F; Tavolato M; Secchi AG
    Eur J Ophthalmol; 2003 Mar; 13(2):128-33. PubMed ID: 12696630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Group comparative trial of 2% nedocromil sodium with placebo in the treatment of seasonal allergic conjunctivitis.
    Stockwell A; Easty DL
    Eur J Ophthalmol; 1994; 4(1):19-23. PubMed ID: 8019118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical levocabastine protects better than sodium cromoglycate and placebo in conjunctival provocation tests.
    Rimås M; Kjellman NI; Blychert LO; Björkstén B
    Allergy; 1990 Jan; 45(1):18-21. PubMed ID: 1968726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twice daily 4% Sodium Cromoglycate vs. 2% Sodium Cromoglycate used four times daily in seasonal (grass pollen) allergic conjunctivitis.
    Collum LM; Fitzsimon S; Hillery M; Collum A; Power WJ; Pelikan Z; Jenson JB
    Doc Ophthalmol; 1992; 82(3):267-77. PubMed ID: 1303863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium cromoglycate eye drops: regular versus "as needed" use in the treatment of seasonal allergic conjunctivitis.
    Juniper EF; Guyatt GH; Ferrie PJ; King DR
    J Allergy Clin Immunol; 1994 Jul; 94(1):36-43. PubMed ID: 8027497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nedocromil sodium and levocabastine reduce the symptoms of conjunctival allergen challenge by different mechanisms.
    Ahluwalia P; Anderson DF; Wilson SJ; McGill JI; Church MK
    J Allergy Clin Immunol; 2001 Sep; 108(3):449-54. PubMed ID: 11544467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New trends in the treatment of allergic conjunctivitis.
    Parys W; Blockhuys S; Janssens M
    Doc Ophthalmol; 1992; 82(4):353-60. PubMed ID: 1363981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter trial of nedocromil sodium, 1% nasal solution, compared with cromolyn sodium and placebo in ragweed seasonal allergic rhinitis.
    Schuller DE; Selcow JE; Joos TH; Hannaway PJ; Hirsch SR; Schwartz HJ; Filley WV; Fink JN
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):554-61. PubMed ID: 2172349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model.
    Friedlaender MH; Harris J; LaVallee N; Russell H; Shilstone J
    Ophthalmology; 2000 Dec; 107(12):2152-7. PubMed ID: 11097587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe.
    Kremer B; Tündermann A; Goldschmidt O
    Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
    Dechant KL; Goa KL
    Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nedocromil sodium as a topical treatment of allergic conjunctivitis due to grasses].
    Pacor ML; Biasi D; Maleknia T; Carletto A; Lunardi C
    Recenti Prog Med; 1996 May; 87(5):215-7. PubMed ID: 8767757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model.
    Netland PA; Leahy C; Krenzer KL
    Am J Ophthalmol; 2000 Dec; 130(6):717-23. PubMed ID: 11124289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind clinical trial wtih cromoglycate eye drops in patients with atopic conjunctivitis.
    Simon-Licht IF; Dieges PH
    Ann Allergy; 1982 Oct; 49(4):220-4. PubMed ID: 6812469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.